Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Clinical Implication CMR in AMI Registry
Recruiting
- Conditions
- Acute Myocardial Infarction
- Interventions
- Procedure: Percutaneous Coronary Intervention
- First Posted Date
- 2021-03-09
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 500
- Registration Number
- NCT04788940
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study
Not Applicable
Recruiting
- Conditions
- Breast Cancer Lymphedema
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT04787029
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Modular mHealth for Tailored Rehabilitation
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT04781712
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid
Not yet recruiting
- Conditions
- Pancreas Cancer
- Interventions
- Other: Organoid
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT04777604
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Long-term Beta-blocker Therapy After Acute Myocardial Infarction
Phase 4
Recruiting
- Conditions
- Myocardial Infarction
- Interventions
- Drug: Discontinuation of β-blocker
- First Posted Date
- 2021-02-24
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 2540
- Registration Number
- NCT04769362
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers
Not Applicable
Terminated
- Conditions
- Squamous Cell CarcinomaResection MarginTongue Cancer TNM Staging Primary Tumor (T) T2Tongue CancerTongue Cancer TNM Staging Primary Tumor (T) T1Surgery
- Interventions
- Procedure: 1.0 cm surgical safety margin for cT1-2N0 oral tongue cancersProcedure: 1.5 cm surgical safety margin for cT1-2N0 oral tongue cancers
- First Posted Date
- 2021-02-04
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 125
- Registration Number
- NCT04738786
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid
Recruiting
- Conditions
- Pancreatic Cancer Resectable
- Interventions
- Other: Organoid
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2021-02-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT04736043
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Real World Difference After Changing Medication From Nonselective to Selective Endothelin Receptor Antagonist in Stable Eisenmenger Syndrome
Not yet recruiting
- Conditions
- Eisenmenger Complex
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT04732650
Development of Fall Prediction Model for Older Adults Based on Multi-faceted Data
Completed
- Conditions
- Gait
- Interventions
- Other: Older adults
- First Posted Date
- 2021-01-26
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT04723927
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Individualized Brain Stimulation Using Transcranial Direct Current Stimulation Simulation in Stroke Patients
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Device: Transcranial Direct Current Stimulation
- First Posted Date
- 2021-01-07
- Last Posted Date
- 2023-02-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT04699331
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath